Algorithme Pharma secures a partnership with Kilmer Capital Partners
Montréal, October 15, 2007 - Algorithme Pharma is very pleased to announce that it has entered into a significant partnership with Kilmer Capital Partners, a leading Canadian investment group. This association will add to the business expertise and financial depth needed to ensure Algorithme Pharma’s plans to expand into new markets.
Since first established in 1992, Algorithme Pharma has continuously demonstrated its commitment to maintaining a high level of customer service and unquestionable quality and reliability through the various phases of its growth to date. Algorithme Pharma’s ultimate goal is, and will remain, providing its customers with the best contract research services.
“Our investment group recognizes the expansion potential of Algorithme Pharma, based on a solid track record of sound management and constant development,” says André La Forge, Managing Partner of Kilmer Capital Partners.
According to Louis Caillé, President and Chief Executive Officer of Algorithme Pharma, “Management and staff are all very enthusiastic about the growth and acquisition opportunities that this partnership will bring. Under the terms of the agreement, there will be no changes in the Company’s management and personnel and the founders and current shareholders will retain significant ownership of the Company. “
About Algorithme Pharma
Algorithme Pharma is one of the world’s leading clinical research and biopharmaceutical analysis companies, specializing in contractual research for the international pharmaceutical industry. The Company conducts over 200 studies annually with the participation of some 7,000 volunteers. A privately held Quebec company, Algorithme Pharma employs over 350 professionals. Algorithme Pharma has experienced tremendous growth – nearly 400% – in the past five years. The Company is headquartered in Laval, Quebec, and operates three other facilities, including its newest and largest, the 68,000 square-foot Beaumont Clinic.
About Kilmer Capital Partners
Kilmer Capital is a private equity investment fund run by experienced investors and business operators dedicated to building pre-eminent companies in partnership with management. They provide patient equity capital to small and mid-market companies seeking financing for expansion, acquisitions, management buyouts, leveraged buyouts, restructurings, recapitalizations and privatizations.
www.algopharm.com
www.kilmercapital.com
- 30 -
SOURCE: Louis Caillé
President and Chief Executive Officer
Algorithme Pharma
CONTACTS:
Frédéric D. Tremblay Maurice Boucher
Public Relations Officer Senior Consultant
Étoile du Nord Public Relations Étoile du Nord Public Relations
(514) 398-9758, ext. 243 (514) 398-9758, ext. 253
ftremblay@etoileworld.com mboucher@etoileworld.com